Wound Dressings Market worth 8.46 Billion USD by 2021 By Marketsandmarkets

By -

The global wound dressings market is expected to reach USD 8.46 Billion by 2021 from USD 6.31 Billion in 2016, at a CAGR of 6.0% from 2016 to 2021. Technological advancements in wound dressings are fueling the growth of this market. In addition, prevalenc

(EMAILWIRE.COM, July 20, 2018 ) Various factors, such as introduction of new and advanced wound dressing products and support in the form of funds and grants from various government bodies across the globe are fueling the growth of this market.

Browse 98 market data tables with 96 figures spread through 184 pages and in-depth TOC on "Wound Dressings Market" 
https://www.marketsandmarkets.com/Market-Reports/wound-dressings-market-123903496.html

The major players operating in global wound dressings market include Smith & Nephew plc (U.K.), Acelity L.P., Inc. (U.S.), Integra Lifesciences Corporation (U.S.), Coloplast Corporation (Denmark), 3M Company (U.S.), Organogenesis Inc. (U.S.), ConvaTec Inc. (U.S.), Hollister Wound Care (U.S.), Mölnlycke Health Care AB (Sweden), and BSN Medical (Germany) which are majorly focused on growing their market through strategies such as new product launches, mergers & acquisitions, geographic expansion, partnerships, and agreements.

Acelity L.P., Inc. (U.S.) accounted for the largest share of the wound dressings market in 2015. It has a diversified product portfolio for wound care and focuses on alliances for inorganic growth, which enabled it to generate maximum revenue from the market. The company was formed through merger of Centaur Guernsey L.P. Inc. and its subsidiaries, which include Kinetic Concepts, Inc., LifeCell Corporation, and Systagenix Wound Management Ltd., in September, 2014.

To maintain its competitive position, the company focuses on new product launches and agreements. The company mainly focuses on the development of new and innovative products to expand its portfolio and address the needs of physicians in the global wound dressings market. In May, 2015, Acelity announced the availability of TIELLE Non Adhesive, a new and improved foam dressing, in the European market. It also announced the availability of Nanova Therapy System, a new absorbent dressing enhanced with negative pressure for slow-to-heal wounds. This development aimed at increasing the company’s reach and market share.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=123903496

Headquartered at Plainsboro, New Jersey (U.S.), Integra LifeSciences Corporation is also a leading player in wound dressings market. The company largely operates in the orthopedic devices market and also offers products in the field of advanced wound management. It strengthens its market presence through new product launches, geographic expansions, and strategic acquisitions. The company strongly focuses on its R&D activities. It has developed innovative wound management products that are highly acclaimed in the U.S. and well accepted in the European region. In July, 2015 Integra LifeSciences Corporation acquired all the shares of TEI Biosciences Inc. and TEI Medical Inc. This acquisition was aimed at helping the company widen its product portfolio of regenerative products, which, in turn, will enhance its customer base.

Press Release: https://www.marketsandmarkets.com/PressReleases/wound-dressings.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more